A Phase 1/1b Dose-Escalation Trial Evaluating CPI-818, An Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, In Subjects With Relapsed/Refractory T-Cell And Follicular B-Cell Non-Hodgkin Lymphoma Read more
A Phase I Trial Assessing The Feasibility Of Romidepsin Combined With Brentuximab Vedotin For Patients With Requiring Systemic Therapy For Cutaneous T-Cell Lymphoma Read more
A Phase 1/2, Open-Label, Dose-Escalation Trial Of GEN3013 In Patients With Relapsed, Progressive Or Refractory B-Cell Lymphoma Read more
Outcomes Of Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Patients: Real World Experience In Lymphoma Patients Read more
Outcomes And Prognostic Factors Of Patients Diagnosed With High-Grade B-Cell Lymphoma, Not Otherwise Specified: A Multi-Institutional Retrospective Study Read more
An Open-Label, Phase 1/2 Study Of JCAR017 In Subjects With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma (017004) Read more
Phase IB/II Of CPX-351 As Maintenance Therapy In AML Patients Ineligible For Bone Marrow Transplantation Read more
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Entospletinib In Combination With Intensive Induction And Consolidation Chemotherapy In Adults With Actively Diagnosed Nucleophosmin 1-Mutated (NPM1) Acute Myeloid Leukemia Read more
